| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5267738
Max Phase: Preclinical
Molecular Formula: C18H20F3N5O
Molecular Weight: 379.39
Associated Items:
Representations
Canonical SMILES: NC(=O)c1ccc(NCc2cccc(N3CCNC(C(F)(F)F)C3)c2)nc1
Standard InChI: InChI=1S/C18H20F3N5O/c19-18(20,21)15-11-26(7-6-23-15)14-3-1-2-12(8-14)9-24-16-5-4-13(10-25-16)17(22)27/h1-5,8,10,15,23H,6-7,9,11H2,(H2,22,27)(H,24,25)
Standard InChI Key: YWYXAMUEUIQTTJ-UHFFFAOYSA-N
Associated Targets(non-human)
tRNA (guanine-N(1)-)-methyltransferase 44 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 379.39 | Molecular Weight (Monoisotopic): 379.1620 | AlogP: 2.13 | #Rotatable Bonds: 5 |
| Polar Surface Area: 83.28 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 5.07 | CX LogP: 1.98 | CX LogD: 1.98 |
| Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.74 | Np Likeness Score: -1.46 |
References
| 1. Wilkinson AJ, Ooi N, Finlayson J, Lee VE, Lyth D, Maskew KS, Newman R, Orr D, Ansell K, Birchall K, Canning P, Coombs P, Fusani L, McIver E, Pisco J, Ireland PM, Jenkins C, Norville IH, Southern SJ, Cowan R, Hall G, Kettleborough C, Savage VJ, Cooper IR.. (2023) Evaluating the druggability of TrmD, a potential antibacterial target, through design and microbiological profiling of a series of potent TrmD inhibitors., 90 [PMID:37187252] [10.1016/j.bmcl.2023.129331] |
Source
Source(1):